Search

Search Constraints

You searched for: Author/Creator Auclin, Edouard

Search Results

11. Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. (July 2021)

12. Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors. (November 2022)

13. REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study. (18th February 2022)

15. Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma. (February 2019)

16. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer. (April 2023)

17. The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma. (25th February 2021)

18. Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy. (March 2021)